Omidvari A-H. Barrett’s oesophagus: endoscopic treatment or surveillance? A comparative cost-effectiveness analysis. UEG Week 2018, OP097.
Pembrolizumab plus mFOLFOX7 of FOLFIRI bij MSS/MMR-proficiënt mCRC
okt 2024 | Immuuntherapie, Maag-darm-leveroncologie